Mechanism of 2-chloroadenosine toxicity to PC3 cell line

被引:9
作者
Minelli, Alba
Bellezza, Ilaria
Agostini, Massimiliano
Bracarda, Sergio
Culig, Zoran
机构
[1] Univ Perugia, Sez Biochim Cellulare, Dipartimento Med Sperimentale Sci Biochim, I-06123 Perugia, Italy
[2] Univ Perugia, Sez Farmacol, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy
[3] Osped Silvestrini, Perugia, Italy
[4] Innsbruck Med Univ, Dept Urol, Innsbruck, Austria
关键词
2-CADO; prostate cancer; ribo-/deoxy-ribonucleotides; DNA biosynthesis enzymes;
D O I
10.1002/pros.20458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. 2-CADO inhibits the growth of several types of cells and causes apoptosis by a mechanism which involves adenosine receptors or cellular uptake or both. METHODS. Androgen-independent (PC3) prostate cancer cells were used in the study and proliferation, cell-cycle progression, and apoptosis analyzed. Deoxy-and ribonucleoside triphosphate pools were determined by HPLC. The molecular mechanism was examined by assessing the involvement of DNA synthesizing enzymes in the cellular response. RESULTS. 2-CADO treatment dramatically reduced the number of prostate cancer cells and permanently stopped cell-cycle progression in the S-phase. The role of 2-CADO in prostate cancer cells is uptake-mediated and followed by sequential phosphorylations to 2-Cl-ATP that irreversibly inhibits several key-enzymes for DNA biosynthesis. CONCLUSIONS. Arrest of DNA synthesis responsible for toxicity of 2-CADO to PC3 cells is due to the lack of substrates for DNA polymerization caused by irreversible inhibition of purine/pyrimidine ribo-and 2-deoxyribonucleotides salvage enzymes.
引用
收藏
页码:1425 / 1436
页数:12
相关论文
共 47 条
[1]   Cytostatic effect of the nucleoside analogue 2-chloroadenosine on human prostate cancer cell line [J].
Bellezza, Ilaria ;
Agostini, Massimiliano ;
Liguori, Lavinia ;
Minelli, Alba .
CURRENT PHARMACEUTICAL ANALYSIS, 2005, 1 (03) :265-272
[2]   Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2′-deoxyadenosine [J].
Bontemps, F ;
Delacauw, A ;
Cardoen, S ;
Van den Neste, E ;
Van den Berghe, G .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (10) :1237-1243
[3]  
Cardoen S, 2001, CLIN CANCER RES, V7, P3559
[4]  
Ceruti S, 2000, J NEUROSCI RES, V60, P388, DOI 10.1002/(SICI)1097-4547(20000501)60:3<388::AID-JNR14>3.0.CO
[5]  
2-V
[6]   INFLUENCE OF 2-CHLOROADENOSINE ON THE NUCLEOTIDE CONTENT OF ISOLATED RAT HEPATOCYTES [J].
CLAEYSSENS, S ;
HAMET, M ;
CHEDEVILLE, A ;
BASUYAU, JP ;
LAVOINNE, A .
FEBS LETTERS, 1988, 232 (02) :317-322
[7]  
COLOMBEL M, 1992, CANCER RES, V52, P4313
[8]   Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours [J].
Culig, Z ;
Steiner, H ;
Bartsch, G ;
Hobisch, A .
ENDOCRINE-RELATED CANCER, 2005, 12 (02) :229-244
[9]  
Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO
[10]  
2-C